|
|
||||||||
1 From the Laser Laboratory, Retina Service, Massachusetts Eye and Ear Infirmary; and the 2 Schepens Eye Research Institute, Harvard Medical School, Boston.
PURPOSE. To examine the effect of combining angiostatin with photodynamic therapy (PDT) using Lutetium Texaphyrin (Lu-Tex; Alcon, Fort Worth, TX) as a photosensitizer in bovine retinal capillary endothelial (BRCE) and retinal pigment epithelial (RPE) cells and to determine the mode of PDT-induced cell death in these cell lines.
METHODS. Cultured BRCE and RPE cells were incubated with angiostatin (500 ng/ml) for 18 hours and subjected to Lu-Tex/PDT, using treatment parameters previously optimized (3 µg/ml Lu-Tex for 30 minutes followed by timed irradiation at 732 nm). Cellular survival was assessed after a 1-week cellular proliferation. Data were analyzed using Students t-test. Caspase 3 activity was monitored in cells after PDT using a fluorogenic substrate, (Asp-Glu-Val-Asp)-AFC (7-amino-4-trifluoromethyl coumarin) [DEVD-AFC], of caspase 3. After PDT, expression of Bcl-2, Bcl-xL, Bax, and Bak was also examined in cell lysates by Western blot analysis.
RESULTS. A synergistic cytotoxic effect of angiostatin and Lu-Tex/PDT was
observed in BRCE cells at all fluences used (5, 10, and 20
J/cm2; P
0.05). These findings
applied only if angiostatin was delivered before PDT. No such
interactive killing effect was observed in RPE cells. Caspase 3
activity was elevated within 10 minutes of PDT in BRCE and RPE cells
and was fluence dependent. Differential modulation of Bcl-2 family
members was observed after PDT in BRCE and RPE cells.
CONCLUSIONS. The combination of angiostatin and Lu-Tex/PDT potentiates the cytotoxic effect of Lu-Tex/PDT on BRCE but not on RPE cells. This may provide a strategy to increase the selectivity of PDT in damaging capillary endothelial cells with less damage to RPE cells. Lu-Tex/PDT induces rapid caspase-dependent apoptosis in BRCE and RPE cells. Furthermore, Lu-Tex/PDT induces apoptosis through selective modulation of members of the Bcl-2 family and differs between BRCE and RPE cells.
This article has been cited by other articles:
![]() |
M. Berdugo, R. A. Bejjani, F. Valamanesh, M. Savoldelli, J.-C. Jeanny, D. Blanc, H. Ficheux, A. Scherz, Y. Salomon, D. BenEzra, et al. Evaluation of the New Photosensitizer Stakel (WST-11) for Photodynamic Choroidal Vessel Occlusion in Rabbit and Rat Eyes Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1633 - 1644. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Matsubara, T. Nakazawa, K. Noda, H. She, E. Connolly, T. A. Young, Y. Ogura, E. S. Gragoudas, and J. W. Miller Photodynamic Therapy Induces Caspase-Dependent Apoptosis in Rat CNV Model Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4741 - 4747. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Husain, I. Kim, D. Gauthier, A. M. Lane, M. K. Tsilimbaris, E. Ezra, E. J. Connolly, N. Michaud, E. S. Gragoudas, C. A. O'Neill, et al. Safety and Efficacy of Intravitreal Injection of Ranibizumab in Combination With Verteporfin PDT on Experimental Choroidal Neovascularization in the Monkey Arch Ophthalmol, April 1, 2005; 123(4): 509 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Z. Renno, Y. Terada, M. J. Haddadin, N. A. Michaud, E. S. Gragoudas, and J. W. Miller Selective Photodynamic Therapy by Targeted Verteporfin Delivery to Experimental Choroidal Neovascularization Mediated by a Homing Peptide to Vascular Endothelial Growth Factor Receptor-2 Arch Ophthalmol, July 1, 2004; 122(7): 1002 - 1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Zacks, E. Ezra, Y. Terada, N. Michaud, E. Connolly, E. S. Gragoudas, and J. W. Miller Verteporfin Photodynamic Therapy in the Rat Model of Choroidal Neovascularization: Angiographic and Histologic Characterization Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2384 - 2391. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |